Please assess the completion status of the following clinical trial:

Trial Title: Recovery After Laparoscopic Hysterectomy With Deep Neuromuscular Blockade and Low Intra-abdominal Pressure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elective laparoscopic hysterectomy (total/subtotal)~* Can read and understand Danish~* Informed consent~Exclusion Criteria:~* BMI \> 30 kg/cm2~* Known allergy to medications that are included in the project~* Severe renal disease, defined by S-creatinine \> 0,200 mmol/L, GFR \< 30ml/min or hemodialysis)~* Neuromuscular disease that may interfere with neuromuscular data~* Lactating~* Impaired liver function~* Indication for rapid sequence induction (esophageal reflux/ hiatus hernia/other cause)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Deep neuromuscular blockade (Type: ACTIVE_COMPARATOR): Drug: Rocuronium Intravenous use: 0.3 mg/kg before intubation and 0,7 mg after intubation followed by infusion with 0,3-0,4 mg/kg/h Other Name: Esmeron
- Moderate neuromuscular blockade (Type: PLACEBO_COMPARATOR): Drug: Rocuronium Intravenous use: 0,3 mg/kg followed by NaCl-infusion Other Name: Esmeron

Based on this trial design, predict the completion outcome and termination type (if applicable).